PASSMORE; David B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for PASSMORE; David B..The latest application filed is for "human monoclonal antibodies to programmed death ligand 1 (pd-l1)".

Company Profile

1.25.25

PASSMORE; David B. - San Carlso CA
Passmore; David B. - Mountain View CA
Passmore; David B. - San Carlos CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1) App 20200062848 - KORMAN; Alan J. ; et al.	2020-02-27
IP-10 antibodies and their uses Grant 9,994,633 - Deshpande , et al. June 12, 2	2018-06-12
Interferon Alpha Antibodies And Their Uses App 20170369568 - Witte; Alison ; et al.	2017-12-28
Methods for preparing interferon alpha antibodies Grant 9,765,141 - Witte , et al. September 19, 2	2017-09-19
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1) App 20170158767 - KORMAN; Alan J. ; et al.	2017-06-08
Human monoclonal antibodies to programmed death ligand 1 (PD-L1) Grant 9,580,505 - Korman , et al. February 28, 2	2017-02-28
Human monoclonal antibodies to programmed death ligand 1 (PD-L1) Grant 9,580,507 - Korman , et al. February 28, 2	2017-02-28
Human Monoclonal Antibodies to Programmed Death Ligand 1 (PD-L1) App 20160362495 - KORMAN; Alan J. ; et al.	2016-12-15
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1) App 20160075782 - Korman; Alan J. ; et al.	2016-03-17
Human monoclonal antibodies to programmed death ligand 1 (PD-L1) Grant 9,273,135 - Korman , et al. March 1, 2	2016-03-01
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1) App 20150337038 - KORMAN; Alan J. ; et al.	2015-11-26
Human monoclonal antibodies to programmed death ligand 1 (PD-L1) Grant 9,102,725 - Korman , et al. August 11, 2	2015-08-11
Antibodies To Il-6 And Their Uses App 20150203574 - Rajpal; Arvind ; et al.	2015-07-23
Ip-10 Antibodies And Their Uses App 20150104866 - DESHPANDE; Shrikant ; et al.	2015-04-16
Antibodies to IL-6 and their uses Grant 8,846,037 - Rajpal , et al. September 30, 2	2014-09-30
Interferon Alpha Antibodies And Their Uses App 20140199328 - Witte; Alison ; et al.	2014-07-17
Nucleic acids encoding interferon alpha antibodies Grant 8,722,870 - Witte , et al. May 13, 2	2014-05-13
Human monoclonal antibodies to BTLA and methods of use Grant 8,580,259 - Korman , et al. November 12, 2	2013-11-12
Antibodies To Il-6 And Their Uses App 20130280266 - Rajpal; Arvind ; et al.	2013-10-24
Interferon Alpha Antibodies And Their Uses App 20130254912 - Witte; Alison ; et al.	2013-09-26
Chemical linkers and cleavable substrates and conjugates thereof Grant 8,461,117 - Sufi , et al. June 11, 2	2013-06-11
Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues Grant 8,461,308 - Cardarelli , et al. June 11, 2	2013-06-11
Human Monoclonal Antibodies To Programmed Death Ligand 1 (pd-l1) App 20130122014 - Korman; Alan J. ; et al.	2013-05-16
Antibodies to IL-6 and their uses Grant 8,436,158 - Rajpal , et al. May 7, 2	2013-05-07
Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1) Grant 8,383,796 - Korman , et al. February 26, 2	2013-02-26
Human Monoclonal Antibodies To Btla And Methods Of Use App 20120288500 - Korman; Alan ; et al.	2012-11-15
Monoclonal Antibodies Against Cd30 Lacking In Fucosyl And Xylosyl Residues App 20120276086 - BLACK; Amelia Nancy ; et al.	2012-11-01
IP-10 antibodies and their uses Grant 8,258,266 - Deshpande , et al. September 4, 2	2012-09-04
Human monoclonal antibodies to BTLA and methods of use Grant 8,247,537 - Korman , et al. August 21, 2	2012-08-21
Antibodies To Il-6 And Their Uses App 20120202285 - Rajpal; Arvind ; et al.	2012-08-09
Antibodies to IL-6 and their uses Grant 8,188,235 - Rajpal , et al. May 29, 2	2012-05-29
CD19 antibodies and their uses Grant 8,097,703 - Rao-Naik , et al. January 17, 2	2012-01-17
Interferon alpha antibodies and their uses Grant 8,025,882 - Witte , et al. September 27, 2	2011-09-27
Human Monoclonal Antibodies To Programmed Death Ligand 1 (PD-L1) App 20110209230 - Korman; Alan J. ; et al.	2011-08-25
Human monoclonal antibodies to programmed death ligand 1 (PD-L1) Grant 7,943,743 - Korman , et al. May 17, 2	2011-05-17
Monoclonal Antibodies Against Prostate Specific Membrane Antigen (psma) Lacking In Fucosyl Residues App 20110028696 - CARDARELLI; Josephine M. ; et al.	2011-02-03
Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues Grant 7,875,278 - Cardarelli , et al. January 25, 2	2011-01-25
Human Monoclonal Antibodies to BTLA And Methods of Use App 20100172900 - Korman; Alan ; et al.	2010-07-08
Chemical Linkers And Cleavable Substrates And Conjugates Thereof App 20100145036 - Sufi; Bilal ; et al.	2010-06-10
Antibodies To Il-6 And Their Uses App 20090317402 - Rajpal; Arvind ; et al.	2009-12-24
Monoclonal Antibodies Against Cd30 Lacking In Fucosyl And Xylosyl Residues App 20090175886 - Black; Amelia Naucy ; et al.	2009-07-09
CD19 Antibodies And Their uses App 20090142349 - Rao-Naik; Chetana ; et al.	2009-06-04
Monoclonal Antibodies Against Prostate Specific Membrane Antigen (PSMA) Lacking in Fucosyl Residues App 20090060908 - Cardarelli; Josephine M. ; et al.	2009-03-05
Human Monoclonal Antibodies To Be Programmed Death Ligand 1 (pd-l1) App 20090055944 - Korman; Alan J. ; et al.	2009-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.